Nigeria Centre for Disease Control: Capacity Development for Preparedness and Response for Infectious Diseases

People in lab coats surrounding Petri dishes Post-mentorship evaluation visit to NCDC’s National Reference Laboratory (Source: NCDC)


The strengthening of national public health institutions (NPHIs) is an essential component of global health protection. The Nigeria Centre for Disease Control and Prevention (NCDC) and Robert Koch Institute (RKI) have been working together on issues related to global health security for more than a decade. In 2019, a Memorandum of Understanding (MoU) institutionalised this collaboration. Building on previous achievements, NCDC and RKI will continue to work together on the NiCaDe II project with the aim of building further capacities in the field of global health protection. The project consists of four sub-projects in the areas of (1) hepatitis and rotavirus (HEP/RVA), (2) antimicrobial resistance (AMR), (3) infection prevention and control (IPC) and (4) research governance capacity (RGC), all of which will collectively strengthen national public health capacity in Nigeria and contribute to pandemic preparedness. The main target groups include employees at NCDC and other national health actors in Nigeria as well as health care professionals working on infectious disease diagnostics, antimicrobial stewardship and infection prevention and control.


Supporting NCDC’s mandate to prevent, detect and control infectious diseases of public health importance by strengthening Nigerian public health capacity and thereby contributing to pandemic preparedness capacity globally.

Thematic priorities

  • Infection prevention and control
  • Laboratory diagnostics
  • Marketing authorisation and safety of medicinal products
  • Outbreak management
  • Strengthening of public health systems
  • Surveillance and reporting



01.01.2023 - 31.12.2025


ca. 3,000,000 Euro

Partner Countries

  • Nigeria

In Cooperation with

  • Nigeria Centre for Disease Control and Prevention (NCDC), Nigeria

Implementing Institution

Robert Koch Institute


Dr. Tim Eckmanns; Prof. C.-Thomas Bock; Dr. Sara Tomczyk; Dr. Flora Haderer

Nordufer 20, 13353 Berlin, Germany


Dr. Chinwe Ochu; Dr. Adedeji Adebayo; Dr. Abiodun Egwuenu; Dr. Tochi Okwor; Dr. Grace Esebanmen

801 Ebitu Ukiwe St, Jabi 900108, Abuja, Federal Capital Territory, Nigeria


Subproject (1): HEP/RVA: Establishing intensified nationwide molecular surveillance of highly infectious viral hepatitis (B, C, E) and rotavirus gastroenteritis (RVA)

  • Training and competence development

    Training of junior scientists and sentinel site teams.

  • Research and provision of evidence

    Risk assessment and molecular characterisation of circulating strains to provide a scientific basis for health policy decisions.


Subproject (2): AMR: Supporting national activities to prevent and control AMR

  • Capacity development

    Scaling up the innovative model diagnostic/antimicrobial stewardship approach to improve the utilisation of blood culture diagnostics in health facilities and to expand national AMR surveillance to new geopolitical zones; building the capacity of the National Reference Laboratory for AMR.

  • Research and provision of evidence

    Investigating local antimicrobial use to inform policy decisions.

Subproject (3): IPC: Consolidating training capacities for IPC at the national and state levels in Nigeria

  • Training and competence development

    Consolidating Nigeria’s capacity to apply the Participatory Approach to Learning in Systems (PALS).

  • Capacity development

    The PALS training and practice approach supports health care workers and organisations in employing multimodal strategies for IPC improvement in the local context.


Subproject (4): RGC: Strengthening research governance at the institutional level

  • Capacity development

    Assessing and improving existing – and establishing new – research governance structures to increase the ability of NCDC to undertake high-quality public health research, thereby providing improved evidence for public health decision-making.